David Welsh

1.3k citations

33 papers · 1.1k indexed · h-index 18

Pulmonary and Respiratory Medicine top 5%
Molecular Biology
Cardiology and Cardiovascular Medicine top 10%
Surgery
Cancer Research top 10%

Co-authors: Andrew J. Peacock Oleg Pak Margaret R. MacLean Almaz Aldashev Margaret M. Harnett Pamela Scott Roger M. Wadsworth Colin Church
Topics: Pulmonary Hypertension Research and Treatments (22 papers)Protein Tyrosine Phosphatases (6 papers)Cardiovascular Function and Risk Factors (6 papers)
Cited by: Pulmonary and Respiratory Medicine Cardiology and Cardiovascular Medicine Cancer Research
Journals: Circulation American Journal of Respiratory and Critical Care Medicine Biochemical and Biophysical Research Communications
Partner nations: United Kingdom United States Italy

In The Last Decade

David Welsh

29 papers receiving 1.1k citations

Peers

Countries citing papers authored by David Welsh

Since Specialization

Citations

This map shows the geographic impact of David Welsh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Welsh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Welsh more than expected).

Fields of papers citing papers by David Welsh

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Welsh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Welsh. The network helps show where David Welsh may publish in the future.

Co-authorship network of co-authors of David Welsh

This figure shows the co-authorship network connecting the top 25 collaborators of David Welsh. A scholar is included among the top collaborators of David Welsh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Welsh. David Welsh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Left ventricular dysfunction and intra-ventricular dyssynchrony in idiopathic pulmonary arterial hypertension 2022 ·International Journal of Cardiology ·Geeshath Jayasekera,(unknown),Christie McComb,(unknown),David Welsh,Colin Church,Martin Johnson,Melanie Brewis,Colin Berry,Aleksandra Radjenovic,Andrew J. Peacock	8
2	Apoptosis signal‐regulating kinase 1 inhibition in in vivo and in vitro models of pulmonary hypertension 2020 ·Pulmonary Circulation ·K. Wilson,(unknown),Kornelija Suveizdytė,John T. Liles,Grant R. Budas,(unknown),Margaret R. MacLean,Martin Johnson,Colin Church,Andrew J. Peacock,David Welsh	5
3	Short-Term Hemodynamic Effects of Apelin in Patients With Pulmonary Arterial Hypertension 2018 ·JACC Basic to Translational Science ·(unknown),Gareth Barnes,Melanie Brewis,Colin Church,Simon Gibbs,Luke Howard,Geeshath Jayasekera,Martin Johnson,Neil McGlinchey,Joelle M. Onorato,Joanne Simpson,Colin Stirrat,(unknown),Geoffrey Watson,Martin R. Wilkins,Carrie Xu,David Welsh,David E. Newby,Andrew J. Peacock	38
4	The role of microRNA-155/liver X receptor pathway in experimental and idiopathic pulmonary fibrosis 2016 ·Journal of Allergy and Clinical Immunology ·Mariola Kurowska‐Stolarska,(unknown),David Welsh,(unknown),(unknown),(unknown),(unknown),Ashley M. Miller,Darren L. Asquith,Neal L. Millar,Ann Millar,Carol Feghali‐Bostwick,Nikhil Hirani,Peter J. Crick,Yuqin Wang,William J. Griffiths,Iain B. McInnes,Charles McSharry	55
5	Nuclear IL-33 regulates soluble ST2 receptor and IL-6 expression in primary human arterial endothelial cells and is decreased in idiopathic pulmonary arterial hypertension 2014 ·Biochemical and Biophysical Research Communications ·Dongmin Shao,Frédéric Perros,Gaetano Caramori,Chao Meng,(unknown),Pai-Chien Chou,Colin Church,Alberto Papi,Paolo Casolari,David Welsh,Andrew J. Peacock,Marc Humbert,Ian M. Adcock,Stephen J. Wort	62
6	Cellular Responses to Hypoxia in the Pulmonary Circulation 2013 ·High Altitude Medicine & Biology ·David Welsh,Andrew J. Peacock	38
7	Low-Dose Fluvastatin Reverses the Hypoxic Pulmonary Adventitial Fibroblast Phenotype in Experimental Pulmonary Hypertension 2012 ·American Journal of Respiratory Cell and Molecular Biology ·C Carlin,(unknown),Oleg Pak,Roger M. Wadsworth,Andrew J. Peacock,David Welsh	17
8	The anti-proliferative effects of apelin on pulmonary adventitial fibroblasts 2012 ·(unknown),Colin Church,Roger M. Wadsworth,Andrew J. Peacock,David Welsh	2
9	Converging Evidence in Support of the Serotonin Hypothesis of Dexfenfluramine-Induced Pulmonary Hypertension With Novel Transgenic Mice 2008 ·Circulation ·Yvonne Dempsie,Ian Morecroft,David Welsh,Neil MacRitchie,(unknown),Lynn Loughlin,Margaret Nilsen,Andrew J. Peacock,Anthony J. Harmar,Michael Bäder,Margaret R. MacLean	78
10	The effects of hypoxia on the cells of the pulmonary vasculature 2007 ·European Respiratory Journal ·Oleg Pak,Almaz Aldashev,David Welsh,Andrew J. Peacock	180
11	The Relationship Between the Components of Pulmonary Artery Pressure Remains Constant Under All Conditions in Both Health and Disease 2007 ·CHEST Journal ·(unknown),John Τ. Reeves,David Welsh,(unknown),Martin Johnson,Andrew J. Peacock	79
12	Fluvastatin Inhibits Hypoxic Proliferation and p38 MAPK Activity in Pulmonary Artery Fibroblasts 2007 ·American Journal of Respiratory Cell and Molecular Biology ·C Carlin,Andrew J. Peacock,David Welsh	29
13	p38 MAP kinase: Essential role in hypoxia-mediated human pulmonary artery fibroblast proliferation 2006 ·Pulmonary Pharmacology & Therapeutics ·(unknown),Andrew J. Peacock,Allan D. Kirk,David Welsh	38
14	The Role of p38 Mitogen-Activated Protein Kinase in Hypoxia-Induced Vascular Cell Proliferation 2005 ·CHEST Journal ·David Welsh,(unknown),Allan D. Kirk,Andrew J. Peacock	8
15	p38 MAP kinase isoform activity and cell cycle regulators in the proliferative response of pulmonary and systemic artery fibroblasts to acute hypoxia 2005 ·Pulmonary Pharmacology & Therapeutics ·David Welsh,Pamela Scott,Andrew J. Peacock	40
16	Proliferation and Signaling in Fibroblasts 2004 ·American Journal of Respiratory and Critical Care Medicine ·David Welsh,Margaret M. Harnett,Margaret R. MacLean,Andrew J. Peacock	86
17	Chronic Hypoxia Induces Constitutive p38 Mitogen-activated Protein Kinase Activity That Correlates with Enhanced Cellular Proliferation in Fibroblasts from Rat Pulmonary But Not Systemic Arteries 2001 ·American Journal of Respiratory and Critical Care Medicine ·David Welsh,(unknown),Margaret R. MacLean,Margaret M. Harnett	71
18	Hypoxia Enhances Cellular Proliferation and Inositol 1,4,5-Triphosphate Generation in Fibroblasts from Bovine Pulmonary Artery But Not from Mesenteric Artery 1998 ·American Journal of Respiratory and Critical Care Medicine ·David Welsh,Pamela Scott,Robin Plevin,(unknown),(unknown)	43
19	Hypoxic Stimulation of the Stress-activated Protein Kinases in Pulmonary Artery Fibroblasts 1998 ·American Journal of Respiratory and Critical Care Medicine ·Pamela Scott,Andrew Paul,Christopher Belham,(unknown),Roger M. Wadsworth,Gwyn W. Gould,David Welsh,Robin Plevin	49
20	Hypoxia Enhances Proliferation and Generation of IP3 in Pulmonary Artery Fibroblasts But Not in Those From the Mesenteric Circulation 1998 ·CHEST Journal ·Andrew J. Peacock,Pamela Scott,Robin Plevin,R. M. Wadsworth,David Welsh	12

About David Welsh

David Welsh is a scholar working on Pulmonary and Respiratory Medicine, Biochemistry and Cancer Research, having authored 33 papers that have together received 1.1k indexed citations. Recurring topics across this work include Pulmonary Hypertension Research and Treatments (22 papers), Protein Tyrosine Phosphatases (6 papers) and Cardiovascular Function and Risk Factors (6 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (714 citations), Cardiology and Cardiovascular Medicine (291 citations) and Cancer Research (184 citations). David Welsh has collaborated with scholars based in United Kingdom, United States and Italy. Frequent co-authors include Andrew J. Peacock, Andrew J. Peacock, Oleg Pak, Margaret R. MacLean, Almaz Aldashev, Margaret M. Harnett, Pamela Scott, Roger M. Wadsworth, Colin Church and Martin Johnson. Their work appears in journals such as Circulation, American Journal of Respiratory and Critical Care Medicine and Biochemical and Biophysical Research Communications.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact